(Reuters) - BioMed Realty Trust Inc (>> Biomed Realty Trust Inc), a real estate investment trust for biotechnology companies, is in talks to sell itself and has attracted interest from private equity firm Blackstone Group LP (>> Blackstone Group LP), Bloomberg reported, citing people familiar with the matter.

Founded in 2004, San Diego-based BioMed has a market value of $3.9 billion (2.54 billion pounds) and is working with Morgan Stanley (>> Morgan Stanley) on a potential deal, the report said. (http://bloom.bg/1MHpEEg)

The talks are ongoing and there is no guarantee a deal will be finalised, one of the sources told Bloomberg.

BioMed, Blackstone and Morgan Stanley could not be immediately reached for comment.

(Reporting by Abhirup Roy in Bengaluru; Editing by Lisa Shumaker)

Stocks treated in this article : Biomed Realty Trust Inc, Morgan Stanley, Blackstone Group LP